Pro Dex Inc PDEX
We take great care to ensure that the data presented and summarized in this overview for PRO DEX INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in PDEX
Top Purchases
Top Sells
About PDEX
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Insider Transactions at PDEX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2025
|
Katrina Marie Kramer Philp Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,200
+11.52%
|
$70,400
$32.7 P/Share
|
|
Nov 21
2025
|
Katrina Marie Kramer Philp Director |
BUY
Grant, award, or other acquisition
|
Direct |
900
+23.68%
|
$28,800
$32.73 P/Share
|
|
Nov 20
2025
|
Katrina Marie Kramer Philp Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+33.33%
|
-
|
|
Nov 20
2025
|
Nicholas John Swenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+1.01%
|
-
|
|
Nov 20
2025
|
Richard Lee Van Kirk Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
72
-0.07%
|
$2,160
$30.83 P/Share
|
|
Nov 20
2025
|
Raymond E Cabillot Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+33.33%
|
-
|
|
Nov 20
2025
|
Alisha Charlton Chief Financial Officer |
SELL
Grant, award, or other acquisition
|
Direct |
1,000
-5.47%
|
-
|
|
Nov 20
2025
|
Alisha Charlton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
72
-0.44%
|
$2,160
$30.83 P/Share
|
|
Nov 20
2025
|
Angelita Rebamontan Domingo Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+6.08%
|
-
|
|
Nov 20
2025
|
Angelita Rebamontan Domingo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
72
-0.5%
|
$2,160
$30.83 P/Share
|
|
Nov 20
2025
|
William James Farrell Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+33.33%
|
-
|
|
Nov 20
2025
|
David Hovda Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+18.87%
|
-
|
|
Jul 24
2025
|
Angelita Rebamontan Domingo Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.1%
|
$630
$42.34 P/Share
|
|
Apr 02
2025
|
Nicholas John Swenson Director |
SELL
Open market or private sale
|
Indirect |
4,526
-0.24%
|
-
|
|
Apr 01
2025
|
Raymond E Cabillot Director |
SELL
Open market or private sale
|
Indirect |
7,263
-2.61%
|
$363,150
$50.01 P/Share
|
|
Mar 31
2025
|
Raymond E Cabillot Director |
SELL
Open market or private sale
|
Indirect |
836
-0.3%
|
$41,800
$50.0 P/Share
|
|
Mar 28
2025
|
Raymond E Cabillot Director |
SELL
Open market or private sale
|
Indirect |
842
-0.3%
|
$42,100
$50.0 P/Share
|
|
Mar 26
2025
|
Raymond E Cabillot Director |
SELL
Open market or private sale
|
Indirect |
3,096
-1.09%
|
$154,800
$50.13 P/Share
|
|
Mar 25
2025
|
Raymond E Cabillot Director |
SELL
Open market or private sale
|
Indirect |
12,927
-2.19%
|
$646,350
$50.67 P/Share
|
|
Mar 24
2025
|
Raymond E Cabillot Director |
SELL
Open market or private sale
|
Indirect |
2,784
-0.93%
|
$139,200
$50.0 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 9.13K shares |
|---|
| Grant, award, or other acquisition | 1K shares |
|---|---|
| Payment of exercise price or tax liability | 216 shares |
| Open market or private sale | 94.5K shares |